Compounds according to the invention bind to and are agonists, antagonists or {HEAD ~ inverse agonists} of the CB2 receptor, and are useful for treating {TAIL ~ inflammation} 
Compounds according to the invention bind to and are agonists , antagonists or { HEAD ~ inverse agonists } of the CB2 receptor , and are useful for treating { TAIL ~ inflammation }
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL